Neurosetta joins the 3Rs Collaborative’s Microphysiological Systems (MPS) Initiative. This working group aims to use MPS technologies, such as the RosetteArray platform, to refine, reduce, and replace the use of animals in research and the commercial chemical/pharmaceutical industry.